Tandem Diabetes Care TNDM EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's EPS (diluted)?
- Tandem Diabetes Care (TNDM) reported EPS (diluted) of -$0.30 in Q1 2026.
- How has Tandem Diabetes Care's EPS (diluted) changed year-over-year?
- Tandem Diabetes Care's EPS (diluted) increased by 84.8% year-over-year, from -$1.97 to -$0.30.
- What is the long-term trend for Tandem Diabetes Care's EPS (diluted)?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's EPS (diluted) has grown at a 91.1% compound annual growth rate (CAGR), from $0.23 to -$3.07.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.